Egypt Harvested Over 700,000 Wheat Feddan since April

Egypt's strategic wheat reserves last until the end of next January (Reuters)
Egypt's strategic wheat reserves last until the end of next January (Reuters)
TT

Egypt Harvested Over 700,000 Wheat Feddan since April

Egypt's strategic wheat reserves last until the end of next January (Reuters)
Egypt's strategic wheat reserves last until the end of next January (Reuters)

Egypt has harvested more than 700,000 feddans of local wheat since the harvest season on April 1.

Egyptian Finance Minister Mohamed Maait said the country allocated $59.69 million for a down-payment to state grain buyers to purchase wheat from local farmers.

Among the world's biggest wheat importers, Egypt is heavily reliant on shipments from Ukraine and Russia, and its government has been seeking alternative supplies from countries including India and France.

Minister of Supply Ali al-Moselhi said Egypt has 2.6 million tons of imported wheat and targets to collect 5.5-6 million tons of local grain; therefore, strategic wheat reserves can last for 6-9 months.

Meanwhile, the Food and Agriculture Organization (FAO) said Ukraine is the eighth wheat producer with about 25 million tons and ranks fifth in corn production with 3.3 million tons.

FOA said that nearly 25 million tons of grains were stuck in Ukraine with blockades at ports due to the war with Russia

Food prices remain high, despite the drop, due mainly to the combination of military conflict in Ukraine and sanctions against Russia.

The FAO's food price index was down just 0.8 percent compared to March.

FAO Deputy Director, Markets and Trade Division Josef Schmidhuber described the situation as "grotesque.”

“We see at the moment in Ukraine with nearly 25 mln tons of grain that could be exported, but that cannot leave the country simply because of lack of infrastructure, the blockade of the ports."

Another concern was that about 700,000 tons of grain may have "disappeared" in Ukraine.

Schmidhuber cautioned that there were no "statistics" about possible theft.

"There's anecdotal evidence that Russian troops have destroyed storage capacity and that they are looting the storage grain that is available," he said. "They are also stealing farm equipment."

The absence of Ukraine as a supplier of grain will put the food supply of the population of Africa in particular at risk, according to the German Kiel Institute for the World Economy (IfW).

IfW trade researcher Henrik Mahlkow explained that due to the war, Ukraine is likely to be initially cut off from the global economy after trade routes have been cut, infrastructure destroyed, and all remaining production factors are likely to be directed towards a war economy.

"As the country is one of the most important grain exporters in the world, and especially relevant for Africa. Losing Ukraine as a supplier will noticeably worsen the supply situation across the continent," said Mahlkow.

According to the institute, the consequences would also be felt in Germany, albeit far less dramatically.

The institute's economists made a trade model to simulate Africa's long-term consequences of an end of exports of Ukrainian wheat and other cereals for food production, such as corn or sorghum.

The model calculations did not include cereals used as animal feed, such as corn. Accordingly, Tunisia and Egypt, in particular, would be negatively affected.

Egypt would import over 17 percent less wheat and almost 19 percent less other cereals, while South Africa would import 7 percent less wheat and over 16 percent less other grains.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.